American Gene Technologies (AGT) CEO and Founder, Jeff Galvin, returns to BioTalk to share updates on their work for a potential functional cure for HIV, the growth of his company, and where they are going next.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
